| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 120.44B | 114.86B | 120.59B | 124.25B | 103.36B | 86.50B |
| Gross Profit | 12.48B | 11.32B | 11.95B | 12.19B | 7.27B | 6.22B |
| EBITDA | 7.81B | 2.65B | 7.64B | 8.32B | 4.75B | 4.84B |
| Net Income | 136.00M | 2.01B | 56.00M | 2.48B | -3.60B | -8.02B |
Balance Sheet | ||||||
| Total Assets | 80.42B | 85.45B | 83.71B | 81.93B | 81.45B | 79.54B |
| Cash, Cash Equivalents and Short-Term Investments | 14.22B | 13.86B | 14.94B | 12.40B | 11.65B | 12.31B |
| Total Debt | 24.66B | 25.83B | 24.75B | 23.87B | 30.72B | 29.34B |
| Total Liabilities | 47.23B | 47.94B | 49.17B | 50.87B | 55.23B | 52.16B |
| Stockholders Equity | 33.19B | 37.50B | 34.54B | 31.06B | 26.22B | 27.38B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.31B | 2.56B | 8.85B | 474.00M | -5.41B |
| Operating Cash Flow | 0.00 | 2.04B | 6.15B | 11.48B | 5.47B | 1.31B |
| Investing Cash Flow | 0.00 | -4.25B | -3.59B | -2.75B | -5.10B | -6.87B |
| Financing Cash Flow | 0.00 | 827.00M | -959.00M | -8.40B | -1.66B | 6.38B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥45.56B | 11.40 | ― | 3.36% | -2.63% | 5.35% | |
74 Outperform | ¥526.52B | 8.11 | 8.58% | 2.62% | 8.21% | 72.79% | |
70 Outperform | ¥379.89B | 12.15 | ― | 1.60% | -0.11% | -21.86% | |
69 Neutral | ¥111.82B | 12.01 | ― | 5.78% | 1.24% | 186.45% | |
65 Neutral | ¥8.76B | 3.91 | ― | 4.24% | -4.75% | 3492.17% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
52 Neutral | ¥17.73B | 9.98 | ― | 3.19% | -1.17% | ― |